Last updated: November 26, 2020
Sponsor: Columbia University
Overall Status: Completed
Phase
2/3
Condition
Chest Pain
Heart Failure
Congestive Heart Failure
Treatment
N/AClinical Study ID
NCT01534663
AAAE8356
Ages 35-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age greater than 18 years,
- left ventricular ejection fraction less than or equal to 35%,
- stable on standard HF medications, and
- optimal medical therapy.
Exclusion
Exclusion Criteria:
- major cardiovascular events,
- procedures in the last 6 months,
- dementia,
- presence of cardiovascular diseases that may lead to harm if the patient took part inthe study (congenital heart disease, long QT syndrome, hypertrophic cardiomyopathy,active myocarditis).
Study Design
Total Participants: 31
Study Start date:
November 01, 2011
Estimated Completion Date:
July 31, 2014
Connect with a study center
Columbia University Medical Center
New York, New York 10032
United StatesSite Not Available
Columbia University Medical Center
New York City, New York 10032
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.